BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7333712)

  • 1. Serial M-mode echocardiography in evaluation of the cardiovascular effects of tiapamil and their relationship to plasma levels in patients with coronary heart disease.
    Lindvall K; Cocco G; Wendt G; Chu D; Heizmann P
    Int J Cardiol; 1981; 1(1):15-24. PubMed ID: 7333712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tiapamil and nifedepine during critical coronary stenosis and in the presence of adrenergic beta-receptor blockade in anesthetized dogs.
    Saini RK; Fulmor IE; Antonaccio MJ
    J Cardiovasc Pharmacol; 1982; 4(5):770-6. PubMed ID: 6182408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hemodynamic effects of intravenous tiapamil in patients with coronary artery disease.
    Bopp P; Mérier G; Scheidegger D; Gabathuler J; Rutishauser W
    Cardiology; 1982; 69 Suppl():91-8. PubMed ID: 7151088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tiapamil on myocardial performance in coronary artery disease.
    Braun S; Miller H; Terdiman R; Laniado S
    Cardiology; 1982; 69 Suppl():79-84. PubMed ID: 7151086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiapamil, a new calcium antagonist: hemodynamic effects in patients with acute myocardial infarction.
    Eichler HG; Mabin TA; Commerford PJ; Lloyd EA; Beck W; Opie LH
    Circulation; 1985 Apr; 71(4):779-86. PubMed ID: 3882269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and hemodynamic effects of tiapamil: exercise performance, thallium stress scintigraphy, and radionuclide ventriculography.
    Eckert M; Pozenel H; Pillat B
    J Clin Pharmacol; 1984 Apr; 24(4):165-73. PubMed ID: 6725618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of tiapamil (Ro 11-1781), a new calcium-entry blocker.
    Gerold M; Eigenmann R; Haeusler G
    J Cardiovasc Pharmacol; 1982; 4(3):419-29. PubMed ID: 6177938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hemodynamic effects of tiapamil and felodipine in essential hypertension at rest and during exercise.
    Lund-Johansen P; Omvik P
    J Cardiovasc Pharmacol; 1990; 15 Suppl 4():S42-7. PubMed ID: 1693726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic effect of intravenous tiapamil on methylergometrine-induced coronary artery spasm in patients with variant angina: randomized double-blind trial.
    Danchin N; Clozel JP; Khalife K; Elkik F; Boulay F; Neimann JL; Cherrier F
    Am Heart J; 1985 Apr; 109(4):764-8. PubMed ID: 3885699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic effects of tiapamil on exercise-induced arrhythmias in patients with coronary artery disease.
    Burkart F; Baitsch G; Braun S; Bertel O; Cocco G
    Cardiology; 1982; 69 Suppl():165-71. PubMed ID: 6758932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute antianginal effect of tiapamil.
    Gasic S
    Cardiology; 1982; 69 Suppl():209-24. PubMed ID: 6758933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a new calcium antagonist, tiapamil, in hypertension of the elderly.
    Balansard P; Elkik F; Levenson JA; Ciampi M; Sans P
    Br J Clin Pharmacol; 1984 Dec; 18(6):823-9. PubMed ID: 6529523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and long-term hemodynamic effects of tiapamil at rest and during exercise in essential hypertension.
    Omvik P; Lund-Johansen P
    Cardiovasc Drugs Ther; 1989 Aug; 3(4):517-23. PubMed ID: 2488103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic effect of the calcium antagonist tiapamil (Ro 11-1781) by intravenous administration in patients with coronary heart disease.
    Nowak FG; Cocco G; Chu D; Gasser DF
    Clin Cardiol; 1980 Dec; 3(6):371-6. PubMed ID: 6161729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of incremental doses of tiapamil on exercise performance in patients with chronic stable angina pectoris.
    O'Keefe JC; Maltz MB; Butrous GS; Camm AJ
    Eur Heart J; 1986 Oct; 7(10):843-7. PubMed ID: 3539614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of tiapamil in patients with mild to moderate essential hypertension.
    Lacourcière Y; Carrier M; Toal CB
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):166-70. PubMed ID: 2475708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of action of tiapamil in stable exercise induced angina.
    Maltz MB; Davies DW; Caplin JL; Camm AJ
    Eur J Clin Pharmacol; 1987; 32(4):339-42. PubMed ID: 3609110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of calcium antagonists in cardiac patients.
    Pozenel H
    Cardiology; 1982; 69 Suppl():85-90. PubMed ID: 7151087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiapamil, a new calcium channel blocking agent for the treatment of effort induced chronic stable angina pectoris.
    Khurmi NS; Robinson CW; O'Hara MJ; Raftery EB
    Eur J Clin Pharmacol; 1986; 30(4):387-92. PubMed ID: 3743614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral tiapamil treatment of arrhythmias in cardiac patients.
    Menzel T; Kirchner P
    Cardiology; 1982; 69 Suppl():192-8. PubMed ID: 6185224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.